Vincenzi Monica, Camilot Marta, Ferrarini Eleonora, Teofoli Francesca, Venturi Giacomo, Gaudino Rossella, Cavarzere Paolo, De Marco Giuseppina, Agretti Patrizia, Dimida Antonio, Tonacchera Massimo, Boner Attilio, Antoniazzi Franco
Azienda Ospedaliera Universitaria Integrata di Verona, Verona, Italy.
BMC Endocr Disord. 2014 Aug 22;14:69. doi: 10.1186/1472-6823-14-69.
Congenital hypothyroidism is often secondary to thyroid dysgenesis, including thyroid agenesis, hypoplasia, ectopic thyroid tissue or cysts. Loss of function mutations in TSHR, PAX8, NKX2.1, NKX2.5 and FOXE1 genes are responsible for some forms of inherited congenital hypothyroidism, with or without hypoplastic thyroid. The aim of this study was to analyse the PAX8 gene sequence in several members of the same family in order to understand whether the variable phenotypic expression, ranging from congenital hypothyroidism with thyroid hypoplasia to mild subclinical hypothyroidism, could be associated to the genetic variant in the PAX8 gene, detected in the proband.
We screened a hypothyroid child with thyroid hypoplasia for mutations in PAX8, TSHR, NKX2.1, NKX2.5 and FOXE1 genes. We studied the inheritance of the new variant R133W detected in the PAX8 gene in the proband's family, and we looked for the same substitution in 115 Caucasian European subjects and in 26 hypothyroid children. Functional studies were performed to assess the in vitro effect of the newly identified PAX8 gene variant.
A new heterozygous nucleotide substitution was detected in the PAX8 DNA-binding motif (c.397C/T, R133W) in the proband, affected by congenital hypothyroidism with thyroid hypoplasia, in his older sister, displaying a subclinical hypothyroidism associated with thyroid hypoplasia and thyroid nodules, in his father, affected by hypothyroidism with thyroid hypoplasia and thyroid nodules, and his first cousin as well, who revealed only a subclinical hypothyroidism. Functional studies of R133W-PAX8 in the HEK293 cells showed activation of the TG promoter comparable to the wild-type PAX8.
In vitro data do not prove that R133W-PAX8 is directly involved in the development of the thyroid phenotypes reported for family members carrying the substitution. However, it is reasonable to conceive that, in the cases of transcriptions factors, such as Pax8, which establish several interactions in different protein complexes, genetic variants could have an impact in vivo.
先天性甲状腺功能减退症常继发于甲状腺发育异常,包括甲状腺缺如、发育不全、异位甲状腺组织或囊肿。促甲状腺激素受体(TSHR)、配对盒基因8(PAX8)、NK2转录因子相关因子1(NKX2.1)、NK2转录因子相关因子5(NKX2.5)和叉头框E1(FOXE1)基因的功能丧失突变导致某些形式的遗传性先天性甲状腺功能减退症,伴或不伴有甲状腺发育不全。本研究的目的是分析同一家族中几名成员的PAX8基因序列,以了解从先天性甲状腺功能减退症伴甲状腺发育不全到轻度亚临床甲状腺功能减退症的可变表型表达是否可能与先证者中检测到的PAX8基因的遗传变异有关。
我们对一名患有甲状腺发育不全的甲状腺功能减退儿童进行了PAX8、TSHR、NKX2.1、NKX2.5和FOXE1基因的突变筛查。我们研究了先证者家族中在PAX8基因中检测到的新变异R133W的遗传情况,并在115名欧洲白种人和26名甲状腺功能减退儿童中寻找相同的替代。进行功能研究以评估新鉴定的PAX8基因变异的体外效应。
在先证者(患有先天性甲状腺功能减退症伴甲状腺发育不全)、其姐姐(表现为亚临床甲状腺功能减退症伴甲状腺发育不全和甲状腺结节)、其父亲(患有甲状腺功能减退症伴甲状腺发育不全和甲状腺结节)以及其表兄(仅表现为亚临床甲状腺功能减退症)的PAX8 DNA结合基序中检测到一个新的杂合核苷酸替代(c.397C/T,R133W)。在HEK293细胞中对R133W-PAX8进行的功能研究表明,其对甲状腺球蛋白(TG)启动子的激活与野生型PAX8相当。
体外数据并未证明R133W-PAX8直接参与携带该替代的家庭成员所报告的甲状腺表型的发展。然而,可以合理推测,对于像Pax8这样在不同蛋白质复合物中建立多种相互作用的转录因子,遗传变异可能在体内产生影响。